These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
616 related items for PubMed ID: 8709780
21. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Crowther MA, Ageno W, Garcia D, Wang L, Witt DM, Clark NP, Blostein MD, Kahn SR, Vesely SK, Schulman S, Kovacs MJ, Rodger MA, Wells P, Anderson D, Ginsberg J, Selby R, Siragusa S, Silingardi M, Dowd MB, Kearon C. Ann Intern Med; 2009 Mar 03; 150(5):293-300. PubMed ID: 19258557 [Abstract] [Full Text] [Related]
25. Von Willebrand factor predicts major bleeding and mortality during oral anticoagulant treatment. Lind M, Boman K, Johansson L, Nilsson TK, Järvholm LS, Jansson JH. J Intern Med; 2012 Mar 03; 271(3):239-46. PubMed ID: 21707795 [Abstract] [Full Text] [Related]
26. Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases. Denas G, Marzot F, Offelli P, Stendardo A, Cucchini U, Russo R, Nante G, Iliceto S, Pengo V. J Thromb Thrombolysis; 2009 Apr 03; 27(3):340-7. PubMed ID: 18338109 [Abstract] [Full Text] [Related]
31. A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy. Palareti G, Legnani C, Lee A, Manotti C, Hirsh J, D'Angelo A, Pengo V, Moia M, Coccheri S. Thromb Haemost; 2000 Nov 03; 84(5):805-10. PubMed ID: 11127860 [Abstract] [Full Text] [Related]
32. Lower versus standard intensity oral anticoagulant therapy (OAT) in elderly warfarin-experienced patients with non-valvular atrial fibrillation. Pengo V, Cucchini U, Denas G, Davidson BL, Marzot F, Jose SP, Iliceto S. Thromb Haemost; 2010 Feb 03; 103(2):442-9. PubMed ID: 20076843 [Abstract] [Full Text] [Related]
33. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. van der Meer FJ, Rosendaal FR, Vandenbroucke JP, Briët E. Arch Intern Med; 1993 Jul 12; 153(13):1557-62. PubMed ID: 8323419 [Abstract] [Full Text] [Related]
34. Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial. Kurtoglu M, Koksoy C, Hasan E, Akcalı Y, Karabay O, Filizcan U, TROMBOTEK Study Group. J Vasc Surg; 2010 Nov 12; 52(5):1262-70. PubMed ID: 20732787 [Abstract] [Full Text] [Related]
35. Complications of oral anticoagulant therapy: bleeding and nonbleeding, rates and risk factors. Hylek EM. Semin Vasc Med; 2003 Aug 12; 3(3):271-8. PubMed ID: 15199460 [Abstract] [Full Text] [Related]
36. Thrombo-embolic and bleeding complications in patients with mechanical valve replacements--a prospective observational study. Schapkaitz E, Jacobson BF, Becker P, Conway G. S Afr Med J; 2006 Aug 12; 96(8):710-3. PubMed ID: 17019493 [Abstract] [Full Text] [Related]
39. Switching from acenocoumarol to warfarin in patients with unstable anticoagulation and its effect on anticoagulation control. Undas A, Cieśla-Dul M, Zółciński M, Tracz W. Pol Arch Med Wewn; 2009 Jun 12; 119(6):360-5. PubMed ID: 19694217 [Abstract] [Full Text] [Related]